Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Check-Cap Ltd.

TRADE

NASDAQ: CHEKHealthcare / Medical Laboratories & Research / Israel
3.73+0.08+2.19%Vol 41 2281Y Perf -81.87%
Oct 17th, 2018 14:46
BID3.72 ASK3.75
Open3.68 Previous Close3.65
Pre-Market- After-Trading-
 - -%  - -%
Target Price
14.00 
Analyst Rating
Strong Buy 1.00
Potencial %
276.34 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)6 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
3.22 
Earnings Date
5th Nov 2018

Today's Price Range

3.553.83

 

52wk Range

3.0823.28

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
4.58%
3 Months
-4.20%
6 Months
-26.56%
1 Year
-81.87%
3 Years
17.74%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CHEK3.730.08002.19
AAPL221.11-1.0400-0.47
GOOG1 114.71-6.5700-0.59
MSFT110.61-0.3900-0.35
XOM81.230.03000.04
WFC54.570.84001.56
JNJ139.432.87002.10
FB158.980.20000.13
GE12.260.16001.32
JPM110.041.42001.31
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.50
Current Ratio 11.30
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage 1 536.60
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio 1.10
PB Ratio 1.06
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -2.80
Cash Flow Per Share -4.21
Price to Tangible Book1.06
Book Value per Share3.50
Enterprise Value (in ths.)9 637
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-70.52
ROE last 12 Months 79.58
Return on Assets (5Y Avg) -27.21
ROA last 12 Months 67.34
Return on Capital (5Y Avg) -30.48
ROC last 12 Months 80.10
Return on invested Capital Q -24.29
Return on invested Capital Y119.08
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.82-0.7014.63
Q01 2018-1.42-1.2611.27
Q04 2017--0.99-
Q03 2017-2.16-1.5627.78
Q02 2017-1.56-2.04-30.77
Q01 2017-1.92-1.920.00
Q04 2016-1.56-1.80-15.38
Q03 2016--0.11-
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.533.64Positive
12/2018 QR-0.543.57Positive
12/2018 FY-2.606.14Positive
12/2019 FY-1.350.74Positive
Next Report Date5th Nov 2018
Estimated EPS Next Report-0.53
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume41 228
Shares Outstanding (in ths.)1 600
Trades Count195
Dollar Volume152 265
Avg. Volume301 117
Avg. Weekly Volume64 019
Avg. Monthly Volume76 685
Avg. Quarterly Volume104 220

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

64%36%

Bearish Bullish

62%38%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x